Julie B Wang

Biographic Data

ID5455408
NAMEJulie B Wang
GIVEN NAMESJulie B
FAMILY NAMEWang
SIGNATUREWANG J B
AFFILIATIONSPublic Service Electric and Gas (United States)
ORCID0000-0001-7039-6061
VERIFIEDYes
TOTAL WORKS7
TOTAL CITATIONS1
AUTHOR COUNT7
EDITOR COUNT0
FIRST PUBLICATION YEAR2009
LATEST PUBLICATION YEAR2024
H-INDEX1

  • MDMA-Assisted Therapy for Posttraumatic Stress Disorder: A Mixed-Methods Case Study of a Participant of Color From an Open-Label Trial

    Open AccessTerence H W Ching, M T Williams et al.ARTICLEJournal of Humanistic Psychology2024References: 46

    MDMA (±3,4-methylenedioxymethamphetamine)-assisted therapy (MDMA-AT) was shown in previous clinical trials to have promising efficacy and safety for alleviating treatment-resistant posttraumatic stress disorder (PTSD). However, due to low ethnoracial diversity, the question remains as to whether ethnoracial minority participants would benefit similarly. Thus, a mixed-methods case study was conducted on a participant of color from an open-label tr…

  • Altered brain activity and functional connectivity after MDMA-assisted therapy for post-traumatic stress disorder

    Open AccessS Parker Singleton, Julie B Wang et al.ARTICLEFrontiers in Psychiatry2023

    https://clinicaltrials.gov/ct2/show/NCT02102802, identifier NCT02102802

  • MDMA-assisted therapy for severe PTSD: A randomized, double-blind, placebo-controlled phase 3 study

    Open AccessJennifer M Mitchell, Michael P Bogenschutz et al.ARTICLENature Medicine2021

    Post-traumatic stress disorder (PTSD) presents a major public health problem for which currently available treatments are modestly effective. We report the findings of a randomized, double-blind, placebo-controlled, multi-site phase 3 clinical trial (NCT03537014) to test the efficacy and safety of 3,4-methylenedioxymethamphetamine (MDMA)-assisted therapy for the treatment of patients with severe PTSD, including those with common comorbidities suc…

  • Scaling Up: Multisite Open-Label Clinical Trials of MDMA-Assisted Therapy for Severe Posttraumatic Stress Disorder

    Open AccessJulie B Wang, Jessica Lin et al.ARTICLEJournal of Humanistic Psychology2021Cited by: 1References: 29

    Background: Posttraumatic stress disorder (PTSD) is a debilitating mental health condition associated with serious adverse health outcomes and functional impairment. Previous MDMA–assisted therapy (MDMA-AT) studies have shown promising results in single site studies. Two open-label studies tested this modality in multisite clinical trials to assess the feasibility of scaling this manualized therapy across 14 North American sites. Method: Cotherap…

  • Medical Marijuana Legalization and Co-use in Adult Cigarette Smokers

    Julie B Wang, Janine K CataldoARTICLEAmerican Journal of Health Behavior2016

    These preliminary findings warrant further examination of the potential impact of long-term legalization of medical marijuana on greater cigarette and marijuana co-use in adults and higher nicotine dependence among co-users at the population level

  • E-cigarette Marketing and Older Smokers: Road to Renormalization

    Janine K Cataldo, Anne Berit Petersen et al.ARTICLEAmerican Journal of Health Behavior2015

    To stem the current epidemic of nicotine addiction, the FDA must take immediate action because e-cigarette advertising promotes dual use and may contribute to the renormalization of smoking

  • Quitting cigarettes completely or switching to smokeless tobacco: Do US data replicate the Swedish results

    S-H Zhu, Julie B Wang et al.ARTICLETobacco Control2009

    The Swedish results are not replicated in the United States. Both male and female US smokers appear to have higher quit rates for smoking than have their Swedish counterparts, despite greater use of smokeless tobacco in Sweden. Promoting smokeless tobacco for harm reduction in countries with ongoing tobacco control programmes may not result in any positive population effect on smoking cessation